KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Income from Continuing Operations (2016 - 2025)

Ionis Pharmaceuticals has reported Income from Continuing Operations over the past 17 years, most recently at 151786000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 151786000.0 for Q4 2025, up 244.54% from a year ago — trailing twelve months through Dec 2025 was 207000.0 (up 99.95% YoY), and the annual figure for FY2025 was 207000.0, up 99.95%.
  • Income from Continuing Operations for Q4 2025 was 151786000.0 at Ionis Pharmaceuticals, up from 128606000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for IONS hit a ceiling of 224613000.0 in Q4 2021 and a floor of 147408000.0 in Q3 2023.
  • Median Income from Continuing Operations over the past 5 years was 83857000.0 (2021), compared with a mean of 55965900.0.
  • Biggest five-year swings in Income from Continuing Operations: surged 1450.73% in 2021 and later plummeted 1033.67% in 2024.
  • Ionis Pharmaceuticals' Income from Continuing Operations stood at 224613000.0 in 2021, then crashed by 123.34% to 52430000.0 in 2022, then surged by 82.33% to 9263000.0 in 2023, then plummeted by 1033.67% to 105012000.0 in 2024, then skyrocketed by 244.54% to 151786000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 151786000.0 (Q4 2025), 128606000.0 (Q3 2025), and 123551000.0 (Q2 2025) per Business Quant data.